WuXiTecan-2 Technology Advances WuXi XDC and Earendil Labs ADC Partnership
WuXiTecan-2 technology leads a new strategic collaboration between WuXi XDC Cayman Inc. and Earendil Labs. The partnership focuses on accelerating next-generation antibody-drug conjugate (ADC) development. Moreover, it combines advanced...

